awmsg logo



collagenase Clostridium histolyticum (Xiapex®)


Reference No. 930

Publication date:
12/01/2012


Appraisal information

collagenase Clostridium histolyticum (Xiapex®) 0.9 mg powder and solvent for solution for injection


Company: Swedish Orphan Biovitrum Ltd
BNF category: Musculoskeletal and joint diseases
NMG meeting date: 05/10/2011
AWMSG meeting date: 09/11/2011
   
   
Submission Type: Full Submission
Status: Superseded
Advice No: 1711
Ministerial ratification: 20/12/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

AWMSG ADVICE SUPERSEDED BY NICE GUIDANCE (ID621) NICE GUIDANCE ISSUED JUNE 2017 (Refer to NICE website for full guidance on NICE recommendations, including any specific restrictions on the use of the technology)
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download